Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ishii N et al. - Randomized controlled trials are necessary to better determine the efficacy and adverse effects of IVIG in the treatment of autoimmune bullous skin diseases. In addition, insights into IVIG's mode of action might enable us to develop novel therapeutics to overcome the current shortage of IVIG.


Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09

Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09

Today in Derm Allergy/Immunology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Solar urticaria
Allergy and Asthma Proceedings, 10/12/09

The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations
Allergy, 11/16/09

Today in Rheumatic/Autoimmune...keeping you current

Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09

Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address